Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chirag D Pathak"'
Autor:
Chirag D. Pathak, Anuradha K. Gajjar
Publikováno v:
Current drug discovery technologies. 19(2)
Background: Diabetes affects millions of people worldwide, with predicted numbers of about 700 million adults affected by 2045. Among the several anti-diabetic drug therapies available in the market, Dipeptidyl Peptidase-4 (DPP-4) inhibitors have eme
Autor:
Jignasa K. Savjani, Chirag D Pathak
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Volume: 52, Issue: 4, Pages: 727-734, Published: DEC 2016
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 727-734
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 727-734
Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 727-734
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 52, Iss 4, Pp 727-734
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 727-734
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 727-734
Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 727-734
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 52, Iss 4, Pp 727-734
Acyclovir is an antiviral drug having potent activity against the virus of herpes family and varicella zoster. Unfortunately, drug suffers very poor oral bioavailability (15-30%). The main objective of present study was to develop acyclovir cocrystal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb741c93bfcd2383c4866967770fc02
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000400727&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502016000400727&lng=en&tlng=en